Page 1472 - Small Animal Internal Medicine, 6th Edition
P. 1472

1444   PART XIV   Infectious Diseases


            Fluoroquinolones can  also be used for  R. rickettsii, Myco-  fungal infections. In these examples, the normal respira-
            plasma,  and  L-form  bacterial  infections.  Bartonella  spp.   tory flora that usually only colonizes the tissues can be
  VetBooks.ir  infections generally are treated with two antimicrobial agents   associated with infection.  Pasteurella spp.  Staphylococcus
                                                                 spp., Streptococcus spp., Mycoplasma spp., and a variety of
            as discussed in the bacteremia section.
              Muscle disease from  T. gondii infection often resolves
                                                                 involved.  Because  the  upper  respiratory  passageways  have
            during treatment with clindamycin hydrochloride, azithro-  gram-negative  organisms  and anaerobic  bacterial  can be
            mycin, or trimethoprim-sulfonamide (see Table 92.4). Pona-  a normal flora, it is difficult to assess the results of culture
            zuril at 20 mg/kg, PO, once daily may also be effective for   and antimicrobial susceptibility testing or polymerase chain
            the treatment of toxoplasmosis. Optimal duration of therapy   reaction results from samples collected from these tissues.
            is unknown, and no drug consistently eliminated T. gondii   The source of the primary insult should always be removed
            from the tissues. Although many dogs with neosporosis die,   if  possible;  see  Chapter  14  for  a  review  of  respiratory
            some have survived after treatment with trimethoprim-  diagnostic techniques.
            sulfadiazine combined with pyrimethamine; sequential   The ISCAID Working Group recommends doxycycline at
            treatment with clindamycin hydrochloride, trimethoprim-  5 mg/kg, PO, q24h or 10 mg/kg, PO, q24h for the initial
            sulfadiazine, and pyrimethamine; or clindamycin alone. For   treatment of cats with acute bacterial URI and dogs with
            dogs with acute Hepatozoon americanum infection, the com-  suspected bacterial causes of the CIRDS (see  Table 92.7).
            bination of trimethoprim-sulfadiazine, pyrimethamine, and   Amoxicillin in cats and amoxicillin-clavulanate in dogs were
            clindamycin for 14 days is highly successful; the use of deco-  considered the alternate empirical choices. If clinical signs
            quinate at 10 to 20 mg/kg q12h with food lessens the likeli-  have not resolved within 10 days, the ISCAID Working
            hood of recurrence of clinical disease and prolongs survival   Group guidelines suggests performing a complete workup,
            time.                                                potentially including deep cultures, before using other anti-
                                                                 biotics like azithromycin, amoxicillin-clavulanate, cefovecin,
                                                                 or fluoroquinolones (Lappin et al., 2017).
            RESPIRATORY TRACT INFECTIONS                           The ISCAID Working Group recommended that dogs or
                                                                 cats with suspected bacterial bronchitis be administered dox-
            Antimicrobial use guidelines (Lappin et al., 2017) for treat-  ycycline while waiting for bacterial culture and antimicrobial
            ment of infectious respiratory diseases in dogs and cats were   susceptibility results. Dogs or cats with uncomplicated com-
            recently published by the Antimicrobial Guidelines Working   munity acquired pneumonia should be administered doxycy-
            Group of the ISCAID. The Working Group made first-choice   cline. Common bacteria associated with pneumonia in dogs
            antimicrobial recommendations for acute bacterial upper   include E. coli, Klebsiella spp., Pasteurella spp., Pseudomonas
            respiratory infections (URIs) in cats, chronic bacterial URIs   spp.,  B.  bronchiseptica,  Streptococcus spp.,  Staphylococcus
            in cats, bacterial causes of the canine infectious respiratory   spp.,  and  Mycoplasma  spp.  In  cats,  Bordetella, Pasteurella,
            disease  syndrome (CIRDS),  bronchitis in dogs and cats,   and Mycoplasma organisms are commonly isolated. Aspira-
            pneumonia in dogs and cats, and pyothorax in dogs and cats   tion of GI contents is a common cause of bacterial pneumo-
            (see Table 92.7).                                    nia with a mixed population of bacteria. Multiple species
              Allergies and irritants most commonly induce serous   of bacteria are typically cultured from dogs and cats with
            nasal discharge, and antibiotics are not indicated in the man-  bronchopneumonia.  Bordetella bronchiseptica and  S. equi
            agement of these syndromes. Many causes of epistaxis are   var. zooepidemicus are the most important primary pathogen
            local to the nasal cavity or sinuses and include trauma,   in dogs and cats; most other bacteria colonize after airways
            foreign bodies, masses, and fungal disease that do not   have been previously damaged. If consolidated lung lobes are
            respond to antibiotic therapy. However, diseases associated   detected radiographically, an anaerobic infection should be
            with vasculitis also are associated with epistaxis; B. vinsonii,   assumed. Dogs or cats with pneumonia and signs of sepsis
            E. canis, and R. rickettsii are implicated most frequently in   should be administered a fluoroquinolone combined with
            this syndrome. Administration of doxycycline may result in   a penicillin or clindamycin parenterally while finishing the
            resolution of disease if these organisms are involved. See   diagnostic workup and then de-escalate therapy as indi-
            Chapters 94 and 95 for a complete discussion of the diagno-  cated (Lappin et al., 2017). Optimal duration of treatment
            sis and treatment of these infectious agents.        for bacterial pneumonia is unknown, but the consensus at
              If mucopurulent nasal discharge is present in dogs or   this  time  is  to  reevaluate  dogs  and  cats  with  pneumonia
            cats  with  other  clinical  manifestations  of  upper  respira-  no later than 10 to 14 days after starting treatment. Addi-
            tory disease like congestion and sneezing, there is usually   tional studies are needed to determine whether the current
            a bacterial component. Primary bacterial pathogens include   recommendations for a minimum of 4 weeks of therapy
            Bordetella bronchiseptica, Chlamydia felis  (cats),  and  some   are needed.
            Mycoplasma spp.,  Pasteurella spp., and  Streptococcus equi,   Whether species of  Mycoplasma infecting dogs and
            var.  zooepidemicus (dogs). Many dogs or cats with sus-  cats are capable of being primary respiratory pathogens is
            pected bacterial URIs have bacterial infections secondary   unknown.  Chlamydia felis in cats is not a common cause
            to other primary diseases, including foreign bodies, viral   of lower respiratory tract infection.  Yersinia pestis causes
            infections, tooth root abscesses, neoplasms, trauma, and   pneumonia in cats in Western states (see  Chapter 99);
   1467   1468   1469   1470   1471   1472   1473   1474   1475   1476   1477